Fundraising Fox
Nob Hill Therapeutics
Albuquerque, US · Founded 2016 · Delaware corporation · 8 employees on LinkedIn · 2 known investors
Find your way into Nob Hill Therapeutics
Sign up to see every warm intro you have to Nob Hill Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nob Hill Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Nob Hill Therapeutics develops inhalation medicines and delivery technologies for high-dose delivery of drugs to the lungs. It aims to create new therapies for lung-related diseases that are currently difficult to treat.
Founders & leadership
Board
CJ
PA
Paul AtkinsBoard director
RC
Robert Calvin GoforthBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$2.4M disclosed across 6 rounds · 2016–2024
▶$1.8MraisedAug 2024 · 17 investors · OtherRule 506(b)
▶$1.8MraisedAug 2024 · 17 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Chris JappDirector
- Noel GreenbergerExecutive Officer, Director
- Paul AtkinsDirector
- Robert Calvin GoforthDirector
- Offering amount
- $3.9M
- Amount sold
- $1.8M
- Minimum investment
- $10K
- Proceeds to insiders
- $55.4K
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b, 4a5
▶$150KraisedSep 2021 · 2 investors · OtherRule 506(b)
▶$150KraisedSep 2021 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Yun LiExecutive Officer, Director
- Paul AtkinsDirector
- Robert Calvin GoforthDirector
- Offering amount
- $600K
- Amount sold
- $150K
- Minimum investment
- $50K
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$50KraisedApr 2021 · 1 investors · OtherRule 506(b)
▶$50KraisedApr 2021 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Robert Calvin GoforthDirector
- Yun LiExecutive Officer, Director
- Offering amount
- $200K
- Amount sold
- $50K
- Minimum investment
- $50K
- First sale
- Apr 2021
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$75KraisedNov 2019 · 1 investors · OtherRule 506(b)
▶$75KraisedNov 2019 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Yun LiExecutive Officer, Director
- Robert Calvin GoforthDirector
- Offering amount
- $500K
- Amount sold
- $75K
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$143.5KraisedNov 2018 · 1 investors · OtherRule 506(b)
▶$143.5KraisedNov 2018 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- R. Calvin GoforthDirector
- Yun LiExecutive Officer, Director
- Offering amount
- $400K
- Amount sold
- $143.5K
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$250KraisedApr 2018 · 1 investors · OtherRule 506(b)
▶$250KraisedApr 2018 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Jee ShinExecutive Officer, Director
- R. Calvin GoforthDirector
- Mark KiddExecutive Officer
- Offering amount
- $250K
- Amount sold
- $250K
- First sale
- Nov 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
Oak hill bioOak Hill Bio develops therapies for patients with rare diseases, supported by experienced life science investors.
BhtherapeuticsBH Therapeutics is a drug development company that uses structure-based rational drug design to identify structural limitations in existing therapies and design novel chemical scaffolds to address them. It develops a pipeline of medicines and conducts clinical trials.
Uber EatsEasiest way for consumers and businesses to order food from favorite local eateries
Companies working in the same space as Nob Hill Therapeutics.
In the news
Frequently asked questions
- What does Nob Hill Therapeutics do?
- Nob Hill Therapeutics develops inhalation medicines and delivery technologies for high-dose delivery of drugs to the lungs. It aims to create new therapies for lung-related diseases that are currently difficult to treat.
- Who are Nob Hill Therapeutics's investors?
- Nob Hill Therapeutics's investors include Houston Angel Network, Tramway Venture Partners.
- How much funding has Nob Hill Therapeutics raised?
- Nob Hill Therapeutics has disclosed $2.4M raised across 6 rounds.
- Where is Nob Hill Therapeutics headquartered?
- Nob Hill Therapeutics is headquartered in Albuquerque, US.